CLINICAL_TRIALS
other
· 2025-12-19
Clinical Trial Update: Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia [Phase 1]
Summary
A Phase 1 clinical trial evaluating pemigatinib after chemotherapy for newly diagnosed acute myeloid leukemia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OHSU Knight Cancer Institute | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING